Variant report
Variant | esv3394209 |
---|---|
Chromosome Location | chr13:69517000-69543360 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:69514136..69516850-chr13:69517321..69519328,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9592587 | chr13:69533621-69533622 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs76977943 | chr13:69533702-69533703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562357197 | chr13:69533780-69533781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201625653 | chr13:69533781-69533782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562619471 | chr13:69533788-69533789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573954918 | chr13:69533837-69533838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs373602127 | chr13:69533838-69533839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9592588 | chr13:69533844-69533845 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs567876382 | chr13:69533845-69533846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371592207 | chr13:69533853-69533854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189080886 | chr13:69533873-69533874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562768385 | chr13:69533892-69533893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370536890 | chr13:69533899-69533900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547238842 | chr13:69533914-69533915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1890977 | chr13:69533915-69533916 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs538792668 | chr13:69533979-69533980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9592589 | chr13:69534039-69534040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372477495 | chr13:69534071-69534072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558878123 | chr13:69534072-69534073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9592590 | chr13:69534086-69534087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs74092919 | chr13:69534106-69534107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538484240 | chr13:69534107-69534108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529943681 | chr13:69534149-69534150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9599364 | chr13:69534176-69534177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577792540 | chr13:69534182-69534183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368293564 | chr13:69534198-69534199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs9592591 | chr13:69534212-69534213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527984677 | chr13:69534221-69534222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376267003 | chr13:69534247-69534248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192121032 | chr13:69534251-69534252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540806190 | chr13:69534266-69534267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545916347 | chr13:69534289-69534290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560700696 | chr13:69534306-69534307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576836151 | chr13:69534317-69534318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79000149 | chr13:69534320-69534321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs67488923 | chr13:69534321-69534322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs398023254 | chr13:69534338-69534339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201250492 | chr13:69534340-69534341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs61950982 | chr13:69534341-69534342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9572054 | chr13:69534346-69534347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148299624 | chr13:69534365-69534366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2325224 | chr13:69534368-69534369 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs9572055 | chr13:69534372-69534373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs59042972 | chr13:69534375-69534376 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs375900007 | chr13:69534467-69534468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139413907 | chr13:69534493-69534494 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576012948 | chr13:69534549-69534550 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114573998 | chr13:69534620-69534621 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200210812 | chr13:69534629-69534630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564820332 | chr13:69534634-69534635 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 22737080 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:69533600-69533800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr13:69533800-69534800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
3 | chr13:69534400-69535200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr13:69534800-69535400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr13:69540800-69541200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr13:69541200-69541600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
7 | chr13:69541400-69542400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr13:69541600-69541800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr13:69541600-69543400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:69541800-69542000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr13:69541800-69542400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr13:69541800-69542400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr13:69541800-69544000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
14 | chr13:69542000-69543800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
15 | chr13:69542400-69543800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
16 | chr13:69542400-69543800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |